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1. Introduction
Eukaryotic DNA is tightly packaged into nucleosome repeats, which form the basic unit of
cellular chromatin. The nucleosome consists of an octamer core wrapped with a segment
of 146 base pairs of double stranded DNA. Each octamer core is composed of two molecules
of  each core histone proteins H2A, H2B,  H3 and H4 (Figure 1).  A fifth histone protein,
linker H1, binds to the nucleosomal core particle and assists in further compaction of the
chromatin into higher-order structure(Lusser and Kadonaga, 2003;Roberts and Orkin, 2004).
This  compaction  of  genomic  DNA  into  chromatin  restricts  access  of  a  variety  of  DNA
regulatory proteins to the DNA strand, which are involved in the processes of transcrip‐
tion, replication, DNA repair and recombination machinery. To overcome these barriers,
eukaryotic cells possess a number of multi-protein complexes which can alter the chroma‐
tin structure and make DNA more accessible.  These complexes can be divided into two
groups,  histone-modifying  enzymes  and  ATP-dependent  chromatin  remodelling  com‐
plexes. The histone-modifying enzymes post-translationally modify the N-terminal tails of
histone proteins through acetylation, phosphorylation, ubiquitination, ADP-ribosylation and
methylation. On the other hand, ATP-dependent chromatin remodelling complexes use the
energy  of  ATP  hydrolysis  to  disrupt  the  contact  between  DNA  and  histones,  move
nucleosomes  along  DNA,  and  remove  or  exchange  nucleosomes(Kallin  and  Zhang,
2004;Lusser and Kadonaga, 2003;Roberts and Orkin,  2004).  The importance of chromatin
structure  and  its  functional  role  in  genome  regulation  and  development  is  becoming
increasingly evident, especially in diseases such as cancer.
© 2013 Xu et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
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Figure 1. Schematic representation of a nucleosome (A) and major histone modifications (B). Modifications on
histones are described in text. The major modifications shown include acetylation (A), methylation (M), phosphoryla‐
tion (P) and ubiquitination (U). Histone modifications mainly occur on the N-terminal tails of histones but also on the
C-terminal tails and globular domains, for example, ubiquitination of the C-terminal tails of H2A and H2B and acetyla‐
tion and methylation of the globular domain of H3 at K56 and K79, respectively.
Intracellular pathogens, through a long-standing coexistence with host cells, have evolved
mechanisms that provide pathogens with the amazing capacity to adapt and survive in the
variable and often hostile environments of their hosts (Galan and Cossart, 2005). The concept
of chromatin modification as a mechanism by which pathogens affect host immune responses
to facilitate infection has emerged in recent years. For example, listeriolysin O (LLO), secreted
by Listeria monocytogenes, induces a dramatic dephosphorylation of histone H3 at serine 10 and
deacetylation of histone H4, and these modifications are associated with changes in host gene
expression during early stages of infection (Hamon et al., 2007). Arbibe and colleagues also
indicate that Shigella flexneri effector OspF dephosphorylates ERK and p38 mitogen-activated
protein kinase (MAPK) in the nucleus; this subsequently prevents histone H3 phosphorylation
at Ser10 at the promoters of a specific subset of genes, which blocks the activation of nuclear
factor –κB (NF-κB)- responsive genes leading to a compromised inflammation in the infected
tissue(Arbibe et al., 2007). These results suggest a strategy developed by microbial pathogens
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to manipulate the host cellular function through histone modification and subversion of host
innate immune responses for their survival or to infect the host.
Histone acetylation/deacetylation is a key epigenetic regulator of chromatin structure and gene
expression, in combination with other posttranslational modifications. These patterns of
histone modification are maintained by histone modifying enzymes such as histone acetyl‐
transferases (HATs) and histone deacetylases (HDACs). While HATs acetylate histones,
conferring an ‘’open” chromatin structure that allows transcriptional activation, HDACs have
the opposite effect resulting in transcriptional repression by closing chromatin structure.
Global HDAC-mediated transcriptional changes can have a concomitant effect on cell function
– an epigenetic mechanism often exploited by viruses to promote infection (Punga and
Akusjarvi, 2000;Radkov et al., 1999;Valls et al., 2007). Recent reports also show that intracellular
bacteria manipulate host cell epigenetics to facilitate infection (Arbibe et al., 2007;Hamon et
al., 2007;Hamon and Cossart, 2008). Disruption of HDAC activity with inhibitors or by siRNA
affects gene expression profilling in different cell types (Glaser et al., 2003a;Glaser et al.,
2003b;Lee et al., 2004;Zupkovitz et al., 2006). The potential of HDAC inhibitors in treatment of
infection has being studied.
In this chapter, the chromatin modifications in host cells induced by bacterial pathogens and
their effects on host gene expression and infection will be reviewed. Furthermore, the potential
role of HDAC inhibitors, as a therapeutic immunomodulator, in treatment of infections will
also be discussed.
2. Chromatin structure in transcription regulation
The packaging of DNA into chromatin does not only simply facilitate the compaction of
eukaryotic DNA genomes into the cell nucleus but also plays a profound and ubiquitous roles
in almost all DNA-related cellular processes such as DNA replication, repair, recombination
and transcription (Clapier and Cairns, 2009;Li et al., 2007a). Chromatin structure is not a simple
static unit. It possesses dynamic properties that are orchestrated by ATP-dependent chroma‐
tin-remodeling complexes and histone-modifying enzymes. In conjunction with other co-
regulators, these chromatin remodelers modify histone-DNA interaction and regulate
transcription at specific genomic loci.
2.1. Histone modifications and transcription
Histone sequences are highly conserved. A core histone protein typically consists of an
unstructured N-terminal tail, a globular core including a central histone-fold domain, and a
conformationally mobile C-terminal tail (Garcia et al., 2007b;Mersfelder and Parthun, 2006).
Both N-terminal tails and globular domains are subject to a variety of posttranslational
modifications (Kouzarides T, Cell, 2007, 128:693-705) (Figure 1). At least fourteen different
types of posttranslational (or covalent) modifications involving more than 60 different residues
on histones have been reported to date including acetylation, methylation, phosphorylation,
ubiquitination, poly-ADP ribosylation, sumoylation, butyrylation, formylation, deimination,
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citrullination, isomerisation, O-GlcNAcylation, crotonylation and hydroxylation (Martin and
Zhang, 2007;Ruthenburg et al., 2007;Sakabe et al., 2010;Tan et al., 2011). The majority of known
histone modifications are located within the N-terminal tails of core histones. These modifi‐
cations play an important role in the control of chromatin dynamics and its availability for
transcription (Kouzarides, 2007). It has been suggested that all these modifications are
combinatorial and interdependent and therefore may constitute a ``histone code`` (Jenuwein
and Allis, 2001;Strahl and Allis, 2000). According to this hypothesis, the “histone code” is read
by effector proteins (readers) which recognize and bind to modifications via specific domains
and result in distinct and consistent cellular processes, such as replication, transcription, DNA
repair and chromosome condensation (Kouzarides, 2007;Shi and Whetstine, 2007). Specific
histone modifications are essential for partitioning the genome into functional domains, such
as transcriptionally silent heterochromatin and transcriptionally active euchromatin (Martin
and Zhang, 2005).
There are two major mechanisms underlying the function of histone modifications (Kouzar‐
ides, 2007;Ruthenburg et al., 2007). The first is the modulation of chromatin structure either by
altering DNA-nucleosome interaction or by altering nucleosome-nucleosome interactions via
changing the histone charges or by addition of physical entities. For example, histone acety‐
lation, a modification associated with transcriptional activation, has been proposed to unfold
chromatin structure via neutralization of the basic charges of lysines (Kouzarides, 2007).
Indeed, in vitro studies using recombinant nucleosomal arrays have demonstrated that
acetylation of H4K16 restricts the formation of a 30-nanometer fiber and the generation of
higher-order structures (Shogren-Knaak et al., 2006;Shogren-Knaak and Peterson, 2006).
Secondly, histone modifications provide docking sites for the recruitment of specific binding
proteins, which recognize and interact with modified histones via specialized domains such
as bromo-, chromo- and PHD (plant homeodomain) domains, thereby influence chromatin
dynamics and function (Wysocka et al., 2005;Wysocka et al., 2006b;Zeng and Zhou, 2002). A
number of proteins have been identified that are recruited to specific modifications. For
example, methylation of H3K4, H3K9 and H3K27 can be recognized by inhibitor of growth
(ING) proteins, heterochromatin protein 1 (HP1) and polycomb proteins, respectively. It has
been shown that histone modification binding proteins can tether, directly or indirectly, an
enzyme to chromatin. The activity of this recruited enzyme can be regulated (Pena et al.,
2006;Shi et al., 2006;Wysocka et al., 2006b). BPTF, a component of the NURF chromatin
remodelling complex, binds to H3K4me3 via a PHD domain and tethers the SNF2L ATPase
to H0XC8 gene and activates the expression of the latter (Wysocka et al., 2006b). JMJD2A and
CHD1, two other H3K4me-binding proteins, possess enzymatic activities themselves and can
directly deliver enzymatic activities to chromatin when recruited (Huang et al., 2006;Pray-
Grant et al., 2005;Sims, III et al., 2005).
The link between histone modifications and transcriptional regulation has been widely
studied. It has been found that a specific modification can be associated with transcriptional
activation or repression. Among the histone modifications, methylation and acetylation of H3
and H4 play a major role in the regulation of transcriptional activity (Berger, 2007;Jenuwein
and Allis, 2001;Li et al., 2007a;Shahbazian and Grunstein, 2007). Methylation, which occurs on
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either a lysine or an arginine residue, is catalyzed by three different classes of methyltransfer‐
ases: SET domain-containing histone methyltransferases (HMTs), non-SET domain-containing
lysine methyltransferases as well as protein arginine methyltransferase (PRMT). Methylation
is implicated in both activation and repression of transcription depending on the methylation
site and the type of methyltransferase involved (Shilatifard, 2006;Wysocka et al., 2006a). For
example, methylation of lysine 4, 36 or 79 of H3 correlates with activation of transcription
whereas methylation of lysine 9, 27 of H3 or lysine 20 of H4 is usually linked to transcriptional
repression (Pawlak and Deckert, 2007). Type I PRMT, such as CARM1 (cofactor associated
arginine methyltransferase 1), PRMT1 and PRMT2, catalyze the formation of monomethyl-
and asymmetric dimethyl-arginine derivatives and is involved in transcriptional activation.
Type II PRMT, such as PRMT5, catalyzes the formation of monomethyl- and symmetric
dimethyl-arginine derivatives and is involved in transcriptional repression. In addition, a
lysine can be mono-, di- or trimethylated with different effect on gene transcription (Santos-
Rosa et al., 2002;Schneider et al., 2005). Both lysine and arginine methylations can be reversed
by histone demethylases, which had been discovered many years after the discovery of HMTs.
LSD1 was the first histone demethylase discovered in 2004 and was shown to demethylate
H3K4 and to repress transcription (Shi et al., 2004). However, LSD1 was also shown to
demethylate H3K9 and activate transcription when present in a complex with the androgen
receptor (Metzger et al., 2005). Following the discovery of LSD1, a number of other related
enzymes were subsequently discovered. Among them, Jumonji domain–containing 6 protein
(JMJD6) is the only direct arginine demethylase reported to date shown to demethylate H3 at
arginine 2 and H4 at arginine 3 (Chang et al., 2007). In addition, human peptidylarginine
deiminase 4 protein (Pad4) can regulate histone arginine methylation by converting mono-
methylated arginine into citrulline via demethylimination or deimination (Cuthbert et al.,
2004;Wang et al., 2004). Histone methylation may affect the binding of other histone-modifying
enzymes to the chromatin, which then mediates other posttranscriptional modifications, such
as histone phosphorylation and DNA methylation (Mosammaparast and Shi, 2010;Pedersen
and Helin, 2010).
Acetylation, another well-characterized modification, occurs on lysine residues mainly in
the N-terminal tail of core histones. However, a lysine 56 within the globular domain of
H3 (H3K56) has been found to be acetylated in yeast. Yeast protein SPT10, a putative histone
acetyltransferase (HAT), was shown to mediate the H3K56 acetylation of histone genes at
their  promoter  regions.  H3K56  acetylation  allows  the  recruitment  of  Snf5,  an  essential
component  of  SWI/SNF  chromatin  remodeling  complex  and  subsequently  regulating
transcription  (Xu  et  al.,  2005).  Compared  with  the  SPT10,  the  Rtt109  acetyltransferase
mediates H3K56 acetylation more globally (Driscoll et al., 2007;Han et al., 2007;Schneider et
al., 2006). The acetylation level correlates with transcriptional activation (Davie, 2003;Legube
and Trouche, 2003). The level of acetylation is balanced by HATs and HDACs. Generally,
increased levels  of  histone acetylation by HATs enhance chromatin decondensation and
DNA  accessibility  for  transcription  factors  to  activate  gene  expression.  In  contrast  to
acetylation, deacetylation of histones catalyzed by HDACs leads to chromatin condensa‐
tion  and gene  silencing  (Berger,  2007;Li  et  al.,  2007a).  The  relationship  between histone
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acetylation and gene expression has been well  documented (Verdone et al.,  2006).  HATs
can also  acetylate  non-histone  proteins,  such as  transcription factors  and nuclear  recep‐
tors to facilitate gene expression (Bannister and Miska, 2000;Masumi, 2011)
Other histone modifications, such as phosphorylation, ubiquitylation and sumoylation, have
also been shown to be involved in transcriptional regulation. For example, H3S10 phosphor‐
ylation has been demonstrated to be involved in the activation of NF-κB-regulated genes as
well as “immediate early” genes, such as c-fos and c-jun (Macdonald et al., 2005). Ubiquitina‐
tion of H2AK119 and H2BK120 are associated with transcriptional repression and activation,
respectively (Wang et al., 2006;Zhu et al., 2005).
2.2. Chromatin remodelling complex and transcription
The second major class of chromatin-modifying factors are the protein complexes that use
energy from ATP hydrolysis to alter nucleosomal structure and DNA accessibility and hence
are generally referred to as chromatin remodeling complex (Flaus and Owen-Hughes,
2004;Saha et al., 2006). Each ATP-dependent chromatin-remodeling complex characterized to
date contains a highly conserved ATPase subunit that belongs to the SNF2 ATPase superfamily
(Marfella CGA, Mutate Res, 2007). Based on the similarities of their ATPase subunits and the
presence of other conserved domains, these complexes can be classified into at least four
different families (Figure 2): the SWI/SNF (mating type switching /sucrose non-fermenting)
family; the ISWI (imitation switch) family; the NuRD/Mi-2/CHD (chromodomain helicase
DNA-binding) family and INO80 (inositol requiring 80) family (Farrants, 2008;Saha et al.,
2006). The ATPase subunits of the SWI/SNF family members, including yeast Snf2 and Sth1,
Drosophila melangaster brahma (BRM) and mammalian BRM and BRG1 (brahma-related gene
1), contain an C-terminal bromodomains which recognize and binds to acetylated histone tails
(Hassan et al., 2002;Marfella and Imbalzano, 2007). The members of ISWI family, such as yeast
homologues ISW1 and ISW2, and mammalian homologues SNF2H and SNF2L, each contains
an ATPase subunit with homology to Drosophila ISWI protein and has nucleosome-stimulated
ATPase activity. These enzymes are characterized by the presence of a SANT (SWI3-ADA2-
NCoR-TFIIIB) domain, which functions as a histone-tail-binding module (Boyer et al., 2004;de
la Serna et al., 2006). SANT domain has been found in a number of transcriptional regulatory
proteins and is therefore thought to play a role in transcriptional regulation (Aasland et al.,
1996;Boyer et al., 2002). The NuRD/Mi-2/CHD family members include a number of proteins
that are highly conserved from yeast to humans and are characterized by the presence of two
N-terminal chromodomains involved in the remodeling of chromatin structure and regulation
of transcription (Brehm et al., 2004;Eissenberg, 2001;Jones et al., 2000). The INO80 family
contains the INO80 remodeling complex (INO80.com) and the SWR1 remodeling complex
(SWR1.com), which are distinguished by the split ATPase domains and the presence of two
RuvB-like proteins, Rvb1 and Rvb2 (Bao and Shen, 2007).
ATP-dependent chromatin remodelers can reposition (slide, twist, or loop) nucleosomes along
the DNA, evict histones from DNA or facilitate exchange of histone variants, and thus creating
nucleosome-free regions for gene activation (Figure 3) (Wang et al., 2007).
Chromatin Remodelling178
Figure 2. ATPase subunits of the four main families of ATP-dependent chromatin remodeling complexes. The
ATPase subunit of each ATP-dependent chromatin-remodeling complex belongs to the SNF2 ATPase superfamily,
whose ATPase domain comprises an N-terminal DExx and a C-terminal HELICc subdomain, separated by an insert re‐
gion. The SWI/SNF family contains an HSA domain for actin binding, and a bromodomain which recognizes and binds
to the acetylated histone tails. The ISWI family contains the SANT and SLIDE domains, important for histone binding.
The CHD/NURD/Mi-2 family is characterized by the presence of two N-terminal chromodomains that is involved in the
remodeling of chromatin structure and the transcriptional regulation of genes. The INO80 family, like the SWI/SNF
family, also contains an HSA domain, however the insert region between the DExx and the HELICc subdomains is three
times longer than that of other three families.
Figure 3. Mechanisms of ATP-dependent chromatin remodeling activity to alter the accessibility of nucleoso‐
mal DNA. Upon utilization of the energy from ATP hydrolysis, the nucleosomal structure is altered to make protected
region of chromatin available to DNA binding protein complexes, such as transcription factors, which involves mobili‐
zation of nucleosome position(sliding), dissociation of DNA-histone contact (unwrapping), and eviction of histones
(histone eviction). In some cases ATP dependent remodeling complexes can use the energy from ATP hydrolysis to in‐
troduce histone variants into the nucleosome (exchange of histone variants), such as H2A–H2B or H2A variants
(H2Avar)–H2B dimers.
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3. The role of chromatin remodelling in the regulation of inflammatory
gene expression
The inflammatory response is a defense mechanism developed in higher organisms to protect
themselves from infection with pathogens. It demands rapid and coordinated regulation of
expression of multiple inflammatory genes in immune cells, including macrophages. It has
increasingly become clear that alterations of chromatin architecture orchestrated by histone
modifications and ATP-dependent chromatin remodeling complexes play a key role in
controlling of inflammatory response genes (Medzhitov and Horng, 2009;Smale, 2010).
3.1. LPS-induced chromatin modification and target gene expression
LPS, a large molecule consisting of a lipid and a polysaccharide joined by a covalent bond, is
the major component of the outer membrane of gram-negative bacteria and is one of the best-
characterized agonist of host inflammatory response. LPS is recognized by Toll-like receptor
4 (TLR4) and activates the downstream signaling pathways, including the NF-κB signaling
cascades, MAPK cascades and interferon regulatory factor (IRF) signaling cascades and induce
the transcription of proinflammatory cytokine genes such as interleukin-6 (IL-6), IL-12 and
tumor necrosis factor (TNF) (Akira and Takeda, 2004;Takeda et al., 2003). The first evidence of
the involvement of chromatin remodeling in LPS-induced gene expression dates back to 1999,
when it was observed that nucleosome remodeling appears to contribute to the rapid induction
of p40 subunit of IL-12 (IL-12p40). Upon activation by LPS, a positioned nucleosome, which
spans the IL-12p40 gene promoter, is rapidly and selectively repositioned prior to initiation of
transcription process (Weinmann et al., 1999). Further studies demonstrated that the nucleo‐
some remodeling by LPS requires TLR4 signaling but is independent of c-Rel, one of the NF-
κB subunits required for transcription of integrated Il-12p40 promoter (Weinmann et al.,
2001). In the year 2000, Saccani and colleagues (Saccani et al., 2002) revealed that upon LPS
stimulation, H3 phosphorylation at serine 10 (H3S10) occurs selectively on the IL-12p40
promoter as well as promoters of a subset of other NF-κB-responsive proinflammatory genes
such as IL-6, IL-8, and CC-chemokine ligand 2 (CCL2) but not TNF-α, MIP-1α and CCL3. This
phosphorylation event was shown to be dependent on the activation of p38 MAPK signaling
pathway by LPS, and specific inhibition of p38 activation blocks H3S10 phosphorylation,
recruitment of NF-κB to the selective promoters and gene expression (Saccani et al., 2002).
Therefore, it is postulated that phosphorylation of H3S10 via the p38 MAPK signaling pathway
promotes the loosening of chromatin at certain selective promoters, thereby permitting
accessibility to NF-κB and allowing transcription to occur. There are some evidence that link
H3S10 mark with transcriptional activation. Serine to alanine substitution at position 10 of H3
or deletion of Snf1, a histone H3 kinase which phosphorylates the serine 10, abrogates
transcriptional activation of LPS- inducible genes (Lo et al., 2001;Lo et al., 2000).
LPS activates TLR-dependent signaling to produce inflammatory cytokines and chemokines,
which contribute to the efficient control and clearance of invading pathogens. However,
production of these inflammatory mediators is tightly regulated because excessive production
results in amplified inflammatory response and fatal illness characteristic of severe septic
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shock. Therefore, the host has readily available mechanisms in place which allow to dampen
the response to LPS or even confer unresponsiveness to successive stimuli with LPS, a
phenomenon named LPS or endotoxin tolerance (Cavaillon and Adib-Conquy, 2006;Cavaillon
et al., 2003). The mechanisms underlying endotoxin tolerance are not completely understood,
but are characterized by impaired TLR-mediated activation of both NF-κB- and MAPK-
dependent genes (Adib-Conquy et al., 2006;Adib-Conquy et al., 2000). Endotoxin tolerance has
been shown to be associated with chromatin remodeling in the promoter regions of several
tolerizable genes (Chan et al., 2005;El et al., 2007). Chang and colleagues have demonstrated
that chromatin remodeling and NF-κB p65 recruitment at the IL-1β gene promoter are altered
in LPS-tolerant THP-1 cells, when compared to normal THP-1 cells (Chan et al., 2005). Upon
LPS treatment, increased phosphorylation of H3S10 and demethylation of H3K9 are observed
in normal THP-1 cells, which represent an “open” chromatin state; however, these modifica‐
tions are impaired in LPS-tolerant cells. Concomitantly, recruitment of NF- κB p65 but not NF-
κB p50 to the IL-1 gene promoter is impaired in LPS-tolerant cells despite that the activation
and nuclear accumulation of NF- κB is not changed. Similar histone modifications and NF- κB
binding were also observed at the TNF-α promoter during endotoxin tolerance (El et al., 2007).
Interestingly, LPS tolerance negatively regulates expression of proinflammatory mediators
without affecting antimicrobial effectors. Using microarrays and real-time PCR, Foster and
colleagues (Foster et al., 2007) identified two classes of genes based on their responsiveness to
re-stimulation with LPS: so called tolerizable genes, which include proinflammatory media‐
tors, and non-tolerizable genes, which include antimicrobial effectors. Induction of tolerance
to LPS inhibits expression of the proinflammatory genes, while the other group of genes remain
inducible. Both classes of gene promoters show H4 acetylation and H3K4 tri-methylation,
which mark an “open” chromatin state, upon initial stimulation with LPS; however, this kind
of “open” chromatin state and recruitment of Brg1 are lost in tolerizable genes upon LPS re-
stimulation. In contrast, these epigenetic marks are maintained in the genes that remain
inducible. Aung and colleagues reported that HDACs are transiently repressed then induced
to express in murine bone marrow-derived macrophages when treated with LPS. HDACs are
recruited to different gene promoters to regulate the expression of the latter.
3.2. Manipulation of host chromatin remodelling process by bacteria to facilitate infection
Interestingly, intracellular pathogens, such as Listeria monocytogenes, Shigella flexneri, and
Helicobacter pylori, affecting the expression of host defense gene via modulation of chromatin
structure has also been reported in recent years. Listeria monocytogenes is a gram positive
bacterium that causes listeriosis. Two different mechanisms have been reported to be used by
L. monocytogenes to modify histones during the course of infection. In endothelial cells, L.
monocytogenes has been shown to selectively induce serine 10 phosphorylation and lysine 14
acetylation of H3 and lysine 8 acetylation of H4 at the IL-8 but not the Interferon-γ (IFN-γ)
gene promoter through the activation of p38 and ERK MAPK pathway. A subsequent study
showed that activation of p38 MAPK signaling pathway and NF-κB by L. monocytogenes
depends on nucleotide-binding oligomerization domain-containing protein 1 (NOD1 ). NOD1
is critical for L. monocytogenes induced secretion of IL-8. Interestingly, only invasive bacteria
which can enter into the host cell cytoplasm induce IL-8 production in endothelial cells (Opitz
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et al., 2006). In another study, L. monocytogenes has been found to induce a dramatic H3
dephosphorylation at serine 10 (H3S10) as well as a deacetylation of H4 during early phase of
infection (Hamon et al., 2007). In contrast to the report described as above, entry of bacteria
into the host cells is not required for these histone modifications. The LLO released by L.
monocytogenes is a member of CDC (cholesterol-dependent cytolysin) toxin family, which is
identified as a major effector sufficient for induction of H3S10 dephosphorylation and H4
deacetylation. LLO –induced H3S10 dephosphorylation specifically occurs in the case of genes
whose expression is regulated by LLO, a number of which are involved in immunity. Inter‐
estingly, other members of the large family of CDC toxins, such as PFO and PLY secreted by
Clostridium perfringens and Streptococcus pneumonia, respectively, dephosphorylate H3S10
through a mechanism analogous to that of LLO (Hamon et al., 2007), suggesting that different
bacteria may subvert immune response through a similar mechanism.
Shigella flexneri is a human intestinal pathogen, causing dysentery by invading the epithelium
of the colon and is responsible, worldwide, for more than one million deaths per year. Arbibe
and colleagues have shown that S. flexneri infection abrogates phosphorylation of H3S10 at the
promoters of a specific subset of genes, such as IL-8 and CCL-20. The underlying mechanism
is that the type III effector protein, OspF, secreted by S. flexneri enters into the nucleus and
specifically dephosphorylates ERK and p38 MAPKs and then blocks MAPK-dependent
phosphorylation of H3S10. This occurs in a gene-selective way, and renders selected gene
promoter sites inaccessible to NF-κB, thereby reducing the expression of a subset of NF-κB-
responsive genes, including IL8 (Arbibe et al., 2007). This specificity might be a consequence
of OspF’s ability to inactivate MAPKs, thereby preventing them from entering into nucleus.
Once activated, MAPKs translocate into nucleus and are recruited to the chromatin covering
their target genes, where they regulate the phosphorylation of transcription factors, histones
and chromatin-remodeling enzymes (Chow and Davis, 2006). It has been shown that OspF–
induced down-regulation of inflammatory response is accomplished through the interaction
of OspF with host retinoblastoma (Rb) protein, which has been linked to histone modification
(Zurawski et al., 2009). OspF also has the phosphothreonine lyase activity, a unique activity
that has been found in a family of conserved effectors secreted by type III secretion system
including OspF, SpvC from nontyphoid Salmonella species, and HopAI1 from the plant
pathogen Pseudomonas syringae (Kramer et al., 2007;Li et al., 2007b;Zhang et al., 2007). These
effectors specifically inactivate their host MAPK pathway by carrying out a β elimination
reaction to irreversibly remove the phosphate moiety from the phosphothreonine in phos‐
phorylated MAPKs. Inhibition of MAPK signaling by OspF attenuates the recruitment of
polymorphonuclear leukocytes to Shigella infection sites by suppressing the activation of a
portion of NF-κB-responsive genes in mice (Arbibe et al., 2007), thereby contributing to the
survival and persistent infection of the pathogens.
Helicobacter pylori is a Gram-negative bacterium that colonizes the human gastric mucosa. The
chronic infection generates a state of inflammation which may develop toward chronic gastritis,
peptic ulcers and gastric malignancies (Peek, Jr. and Crabtree, 2006). The virulence factors of
Helicobacter pylori have been suggested to play a crucial role in the development of inflamma‐
tion and in affecting the host immune system (Gebert et al., 2003;Lu et al., 2005). For example, in
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mouse macrophage, H. pylori peptidyl prolyl cis-, trans-isomerase (HP0175) has been shown to
induce H3S10 phosphorylation at the IL-6 promoter resulting in increased IL-6 gene transcrip‐
tion and protein expression (Pathak et al., 2006). HP0175-induced IL-6 gene transcription is
dependent on the TLR4 –dependent activation of ERK and p38 MAPKs, which subsequently
activate mitogen- and stress-activated protein kinase 1 (MSK1), a serine kinase responsible for
H3S10 phosphorylation. This modification allows for recruitment of NF-κB to the IL-6 promot‐
er and activation of gene transactivation. Interestingly, H. pylori infection has also been shown
to dephosphorylate H3S10 and deacetylate H3K23 in a time- and dose- dependent manner in
gastric epithelial cells (Ding et al., 2010). Therefore, the effect of a specific histone modification
in host cells appears to be cell type specific and gene promoter specific. Further studies demon‐
strate that cag pathogenicity island (PAI) is responsible for the dephosphorylation of H3S10 and
this modification is independent of ERK and p38 signaling pathways as well as IFN signaling.
In addition, H3S10 dephosphorylation is associated with changes in the host gene expression,
which contributes to bacterial infection and pathogenesis (Ding et al., 2010). Treatment of gastric
epithelial cells with TSA, a general inhibitor of HDACs which non-specifically increases histone
H3 and H4 acetylation at multiple sites results in altered gene transcription pattern in both IL-8
and c-fos genes upon H. pylori infection. TSA reduces IL-8 but increases c-fos gene transcrip‐
tion in the presence of H. pylori infection (Ding et al., 2010). H. pylori has also been shown to
regulate the cell cycle controlled protein p21(WAF), which is associated with the release of
HDAC-1from the promoter and histone H4 acetylation (Xia et al., 2008).
4. Chromatin remodeling and IFN-γ-induced transcriptional response
IFN-γ is a cytokine secreted by activated T cells and natural killer cells. IFN-γ can induce
expression of  the major histocompatibility complex class II  (MHC-II)  on the cell  surface
(Boehm et  al.,  1997),  which presents antigens to CD4+  T cells and plays a crucial  role in
normal immune response. IFN-γ activates gene expression mainly via the activation of JAK
(Janus tyrosine kinase)/STATI (signal transducer and activator of transcription) signaling
pathway, leading to the translocation of active STAT1 homodimers into the nucleus. The
STAT1 homodimers then bind to the IFN-γ -activated sites (GAS) present in the promot‐
ers of IFN-γ -responsive genes thereby mediating the transcription of these genes, includ‐
ing class II transactivator (CIITA), which is necessary for both constitutive and inducible
expression of MHC-II (Schroder et al., 2004).
Chromatin remodeling, mediated by ATP-dependent chromatin remodeling complex and
or histone-modifying enzymes, has also been shown to be involved in the activation of IFN-
γ -responsive genes, such as CIITA and HLA-DR (Ni et al., 2005;Pattenden et al., 2002;Zika
et al., 2003). SWI/SNF complex often cooperates with histone-modifying enzymes to regulate
transcription of genes, including those which are induced by IFN-γ (Chi, 2004;Wright and
Ting,  2006).  Studies  have  demonstrated  that  the  SWI/SNF  complex  and  CREB-binding
protein  (CBP),  a  transcriptional  co-activator  with  histone  acetyltransferase  activity,  are
recruited  to  CIITA  promoter  in  an  IFN-γ-inducible  fashion,  leading  to  transcriptional
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activation of  CIITA (Kretsovali  et  al.,  1998;Pattenden et  al.,  2002).  HLA-DR is  a  MHC–II
surface molecule whose transcriptional activation is tightly associated with CIITA. Howev‐
er,  forced  expression  of  CIITA in  BRG1-  and  BRM-deficient  SW13  cells  cannot  activate
expression of the MHC-II genes (Mudhasani and Fontes, 2002). BRG1 or BRM represent the
catalytic subunit of mammalian SWI/SNF chromatin remodeling complex, suggesting that
the  SWI/SNF  complex,  which  contains  BRG1  might  play  additional  roles  in  MHC-II
expression. Further studies have indicated that BRG1 is recruited by CIITA to the MHC-
II gene promoters and this recruitment is essential for activation of MHC-II gene expres‐
sion (Mudhasani and Fontes, 2002). Interestingly, CIITA itself has intrinsic HAT activity,
which can bind not onlyBRG1 but also HATs, such as CBP and/or p300 (Ting and Trowsdale,
2002). Furthermore, CIITA is associated with increased acetylation modifications of H3 and
H4 at  MHC-II  promoter  mediated  directly  through its  intrinsic  HAT activity  or  by  the
recruitment of HATs, such as CBP (Beresford and Boss, 2001;Kretsovali et al., 1998). IFN-γ
induced  transactivation  of  CIITA  and  expression  of  MHC-II  is  inhibited  by  HDACs/
mSin3A corepressor complex whereas enhanced by TSA, a general inhibitor of HDAC. Co-
immunoprecipitation assay revealed that CIITA interacts strongly with HDAC1 and weakly
with HDAC2 (Zika et al.,  2003). All these data suggest that CIITA may act as a modula‐
tor to coordinate functions of chromatin remodeling complex, HATs and HDACs.
In the context  of  host-pathogen interaction,  intracellular  pathogens have been shown to
subvert the host immune response by affecting the macrophage responsiveness to IFN-γ
but the underlying mechanism remains unclear. Intracellular pathogens may affect IFN-γ
response via different ways.  For example,  Leishamania donovani  inhibited IFN-γ response
through down-regulation of IFN-γ receptor expression or interfering with the JAK/STAT1
signaling pathway (Nandan and Reiner,  1995;Ray et  al.,  2000).  By contrast,  mycobacteria
such as Mycobacterium avium and Mycobacterium tuberculosis impair IFN-γ response through
inhibition of IFN-γ -responsive gene expression without interfering with the JAK/STAT1
signaling pathway (Kincaid EZ, J Immunol, 2003, 171:2042-2049). Interestingly, only a subset
of IFN-γ responsive genes get affected, including CIITA, HLA-DR and CD64, while others
remained unaffected (Pennini et  al.,  2006;Wang et  al.,  2005).  Further studies showed that
infection with M. tuberculosis affects the chromatin remodeling on CIITA gene since IFN-γ
-induced histone acetylation and recruitment of BRG1 were both impaired (Pennini et al.,
2006). Additionally, LpqH, a mycobacterial cell wall protein, induces binding of the C/EBP
transcriptional  repressor  to  the  CIITA  promoter  and  inhibits  IFN-γ  -induced  CIITA
transcription  (Pennini  et  al.,  2007).  It  has  been  shown that  C/EBP can  recruit  HDAC-1-
containing transcriptional repressor complex to the promoter of peroxisome proliferator-
activated receptor beta thereby inhibiting its transcription (Di-Poi et al.,  2005).  Therefore,
M. tuberculosis  might induce the recruitment of C/EBP resulting in transcriptional repres‐
sion.  The  exact  molecular  mechanism  by  which  M.  tuberculosis  inhibits  IFN-γ  -induced
CIITA transcription remains to be elucidated. Similarly to CIITA, IFN-γ -induced histone
acetylation gets  impaired at  the  HLA-DR promoter  and HLA-DR transcription becomes
inhibited when the cells get infected with M. tuberculosis. Furthermore, inhibition of HDAC
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activities  rescues  histone  acetylation,  suggesting  a  role  of  HDACs in  the  transcriptional
repression induced by M. tuberculosis  (Wang et al.,  2005). Indeed, Mycobacterial infection
increases the expression of mSin3A (a co-repressor associated HDACs), enabling competi‐
tion with CBP for binding to the HLA-DR promoter.
A recent study has demonstrated that infection with Toxoplasma gondii renders murine
macrophages globally unresponsive to IFN-γ stimulation without affecting the nuclear
translocation of STAT1 triggered by IFN-γ in infected macrophages. However, the binding of
STAT1 to the STAT1-responsive promoters is aberrant. A number of genes, which were
induced by IFN-γ in uninfected macrophages, were not induced in the T. gondii-infected cells.
Among them, there are several genes previously shown to be repressed by T. gondii, such as
CIITA, MHC class II molecule H2-Eα, and interferon- regulatory factor 1(IRF-1) (Lang et al.,
2012). By analyzing the underlying mechanism, the authors revealed that assembly of chro‐
matin remodeling complex and histone acetylation at the IFN-γ -responsive promoters are
impaired upon infection with T. gondii. Treatment with HADC inhibitor restores the respon‐
siveness of T. gondii-infected macrophages to IFN-γ, leading to an increase in the expression
of IFN-γ-inducible genes, such as CIITA and H2-A/E.
5. The potential role of HDAC inhibitors in treatment of infection
HDAC inhibitors have been developed clinically for cancer therapy due to their abilities to
induce  cell-cycle  arrest  and  apoptosis  (Adcock,  2007).  Studies  have  demonstrated  that
HDAC inhibitors can exert anti-inflammatory effects via the suppression of cytokine and
nitric oxide production (Blanchard and Chipoy, 2005;Dinarello et al., 2011), suggesting their
therapeutic potential in inflammatory diseases including infectious diseases. For example,
HDAC inhibitors have been examined for the treatment of HIV infection and the current
results are exciting and encouraging (Wightman et al., 2012). Couple of other studies have
demonstrated that HDAC inhibitors, TSA and apicidin, can inhibit the growth of Plasmodi‐
um falciparum, the main parasite causing malaria in humans (Colletti et al., 2001a;Colletti et
al.,  2001b).  Similarly,  azelaic  bishydroxamic  acid  and suberohydroxamic  acid,  two other
HDAC inhibitors,  also  show anti-malarial  activity  against  P.  falciparum  (Andrews  et  al.,
2000). The potential of HDAC inhibitors as anti-bacterial agents has also been investigat‐
ed; however, the results are contradictory.
5.1. Inhibition of infection by targeting histone modifying enzymes in the pathogen
Candida albicans is an opportunistic pathogen that is normally found in the gut microflora of
healthy individuals; however, C. albicans can cause severe and life-threatening diseases in
immuosuppressed patients such as HIV infected, organ transplant and cancer chemotherapy
patients (Tzung et al., 2001). There is a very high rate of mortality from systemic candidiasis,
ranging between 14 and 90% and averaging between 30 to 40%, depending on the disease
group studied (Blot et al., 2003). For patients with Candida infections, antifungal drug resistance
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is a major clinical problem. H3K56 acetylation is mediated by HAT Rtt109 and seems to be
much more abundant in yeasts than in mammals (Garcia et al., 2007a;Xie et al., 2009), and close
homologues of Rtt109 have not yet been detected in mammals (Bazan, 2008). Therefore, it is
expected that Rtt109 might be a unique target for antifungal therapeutics. Indeed, Wurtele and
colleagues demonstrated that modulation of the acetylation of H3K56 exhibits potential as an
anti-fungal therapy (Wurtele et al., 2010). Interestingly, similar results have been found in a
study by Lopes da Rosa et al (Lopes da et al., 2010). Wurtele and colleagues showed that deleting
Rtt109, an acetyltransferase of H3K56, leads to increased sensitivity to some anti-fungal drugs.
Both teams also demonstrated that Rtt109 mutants are considerably less virulent in a mouse
model infected with C.albicans. Wurtele and colleagues further investigated how the growth
of C. albicans is affected by chemical modification of H3 in vitro and in vivo. They have observed
that the growth of C. albicans is greatly inhibited when HST3, the H3 deacetylase acting on
lysine 56, is inhibited by nicotinamide (a form of Vitamin B3 and product of the NAD+-
dependent deacetylation reaction). Furthermore, modulation of H3K56 acetylation reduces the
virulence of wild-type C. albicans in mice when nicotinamide was given in the drinking water
of mice to repress HST3 (Wurtele et al., 2010). These results, together with the study by Lopes
da Rosa and colleagues, provide basis for targeting H3 modifying enzymes to fight fungal
infections. Although important catalytic residues in Rtt109 are much different from those in
mammalian homologues, it is still a challenge to find suitable fungal-specific inhibitors of H3
modifying enzymes in the future.
5.2. Effects of HDAC inhibitors on host defense against bacterial infection
In a mouse model of septic shock induced by LPS, administration of of suberoylanilide
hydroxamic acid (SAHA) (50mg/kg intraperitoneally), improves long-term survival rates of
mice whether given before or post a lethal dose of LPS, which may be due to the down-
regulation of MyD88-dependent pathway and decreased expression of proinflammatory
mediators such as TNF-alpha, IL-1β, and IL-6 (Li et al., 2010;Li et al., 2009). Further studies
demonstrated that treatment with SAHA increases anti-inflammatory IL-10 levels while
decreasing proinflammatory IL-6 and MAP kinase production in the liver of septic shock mice
(Finkelstein et al., 2010). In contrast, it has also been shown that treatment with HDAC
inhibitors lead to impaired host defense against bacterial infections. Studies have shown that
HDAC inhibitors, TSA, SAHA, and VPA, can impair innate immune responses to TLR agonists
by down-regulating the expression of genes involved in microbial sensing, such as C-type
lectins and adhesion molecules, as well as genes involved in host defense, such as cytokines
and chemokines, thereby increasing susceptibility to infection (Roger et al., 2011). Interestingly,
while LPS-induced IFN-β production is enhanced by HDAC inhibitors, the expression of a
number of IFN-β /STAT1-dependent genes is strongly inhibited by TSA and VPA, suggesting
that increased IFN-β production cannot overcome the potent inhibitory effects of HDAC
inhibitors. Surprisingly, VPA was shown to increase the mortality of mice infected with C.
albicans or K. pneumonia, but protect mice from toxic shock and severe sepsis in mouse models
(Roger et al., 2011). When murine macrophages were treated with TSA and VPA, their ability
to kill Escherichia coli and Staphyloccocus aureus was attenuated, with impaired phagocytosis
and production of reactive oxygen and nitrogen species (Mombelli et al., 2011). Together, these
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data reveal the complex effector mechanisms of HDAC inhibitors and suggest that more
studies are required to fully understand this complex process.
6. Concluding remarks
The activation and suppression of  innate immunity are central  principles  of  host-patho‐
gen  interaction  and  need  to  be  very  well  controlled.  To  establish  persistent  infection,
intracellular  pathogens  must  acquire  efficient  mechanisms  to  evade  the  host  immune
response. Interference with host posttranscriptional modifications by bacterial pathogens is
a strategy widely used by the pathogens to promote survival and replication during the
course of infection. MAPK, IFN-γ and transcription factor NF-κB signaling pathways are
common targets for bacteria-induced posttranscriptional modifications (Ribet and Cossart,
2010). Interestingly, in the past few years, evidence has accumulated that targeting of histone
modifications and chromatin remodeling, and subsequently subverting the host immune
response, is a new and exciting field in the study of host-pathogen interaction. Phosphory‐
lation of H3 and acetylation of H3 and/or H4 at lysine residues are frequently associated
with transactivation. Conversely, dephosphorylation and methylation of histones are more
often associated with gene suppression (Berger, 2002;Kouzarides, 2007;Verdone et al., 2006).
Several strains of bacteria, including L. monocytogenes,  C. perfringens,  S. pneumonia  and H.
pylori, induce the same dephosphorylation of H3S10, while S. flexneri blocks phosphoryla‐
tion of H3S10; all of which lead to decreased phosphorylation of H3S10 and are associat‐
ed with altered host immune response.
The molecular mechanisms by which bacterial infection induces histone modification and
chromatin remodeling remain to be understood. For many pathogens, it is very difficult to
hypothesize  about  the  extent  or  the  mechanics  of  epigenetic  change they might  induce.
Currently available data largely provide snapshots of what is happening to the usual host
genes studied in an infection model. More comprehensive global studies, such as ChIP-on–
chip (chromatin immunoprecipitation coupled with expression microarray technology) for
mapping  global  chromatin  modifications,  are  now  necessary  and  possible.  This  might
provide  fundamental  clues  to  better  understand  the  role  and  mechanism  of  chromatin
regulation  in  the  control  of  immune  gene  expression  in  inflammatory  and  infectious
diseases.
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